Clinical trial · Interventional
One-Page Truth-Telling Aid for Cancer Disclosure
A One-Page Truth-Telling Aid for Cancer Disclosure in Taiwan: A Two-Arm Pragmatic Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical trial is to learn whether a one-page communication aid can improve communication between physicians and patients with cancer during cancer-related truth-telling consultations. The one-page aid is designed to help physicians quickly understand patients' preferences and needs before the consultation. The main questions it aims to answer are: * Does the one-page communication aid improve patients' satisfaction with how cancer-related information is explained? * Does the one-page communication aid reduce patients' emotional distress after the consultation? * Does the one-page communication aid improve physicians' confidence in communicating cancer-related information? Researchers will compare patients whose physicians receive the one-page communication aid with patients whose physicians provide usual care with a blank sheet for patients to write down questions. This comparison will help determine whether the one-page aid improves communication, emotional outcomes, and physician confidence. Participants will: * Complete questionnaires before and after the consultation * Receive either the one-page communication aid or a blank sheet, depending on their physician's group * Complete follow-up questionnaires at 3 months and 6 months after the consultation Physicians will also complete brief questionnaires about their communication confidence at baseline, 1 week after recruitment of their first enrolled patient, 3 months, and 6 months.
Conditions
Conditions (6)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Communication About Health Information | — | UNRESOLVED | — |
| Communication Research | — | UNRESOLVED | — |
| Disclosure | — | UNRESOLVED | — |
| Neoplams | — | UNRESOLVED | — |
| Physician-Patient Relations | — | UNRESOLVED | — |
| Preference, Patient | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blank Sheet | Behavioral | — | UNRESOLVED |
| One-Page Truth-Telling Aid | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- One-Page Truth-Telling Aid
- description
- Patients in this arm will receive the One-Page Truth-Telling Aid before the truth-telling consultation. The aid will be completed with the patient before the visit and summarizes the patient's disclosure preferences, communication needs, and questions for the physician. Patients will be encouraged to provide the aid to their participating physician at the beginning of the consultation so that the physician can quickly understand the patient's preferences and tailor communication accordingly.
- interventionNames
- Behavioral: One-Page Truth-Telling Aid
- type
- ACTIVE_COMPARATOR
- label
- Blank Sheet
- description
- Patients in this arm will receive a blank sheet before the truth-telling consultation. The blank sheet may be used to write down questions or concerns the patient would like to discuss with the physician. It does not include structured questions about disclosure preferences or communication needs. Patients will receive usual care and may choose whether to provide the blank sheet to their participating physician during the consultation.
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
【Physicians】 * Inclusion Criteria: * Physicians who provide clinical care for patients with cancer in participating outpatient departments. * Physicians who are involved in cancer-related truth-telling or disclosure consultations. * Physicians who are willing to participate and provide informed consent. * Exclusion Criteria: * Physicians who are unable or unwilling to complete study procedures or follow-up assessments. 【Patients】 * Inclusion Criteria: * Patients diagnosed with cancer. * Patients who are scheduled to receive cancer-related information from a participating physician, including information about diagnosis, recurrence, metastasis, end-of-life status. * Patients who are able to communicate in Mandarin Chinese or Taiwanese. * Patients who are able to complete questionnaires independently or with assistance from the research assistant. * Patients who are willing to participate and provide informed consent. * Exclusion Criteria: * Patients who are unable to provide informed consent. * Patients with severe cognitive impairment, severe physical illness, or emotional distress that prevents participation, as judged by the clinical team or research staff. * Patients who are unable to complete the study questionnaires even with assistance.
References
Publications (0)
Data not yet available